Effects of shRNA targeting VEGF on VEGF mRNA expression in gastric cancer cells

Abstract

In order to investigate the inhibitory effect of plasmid-mediated short hairpin RNA targeting vascular endothelial growth factor (VEGF) on the expression of VEGF mRNA in human gastric cancer cells, a plasmid vector for transcribing specific short hairpin RNA targeting VEGF (pU6-VEGF) was constructed, and then transfected into human gastric cancer cells using Lipofectamine2000. The VEGF mRNA expression level was detected by RT-PCR. RPMI1640 was used for blank control, and pSilencer 1.0-U6 empty plasmid for the negative control. Results showed the clone and sequence analysis revealed that the recombinant plasmid vector of pU6-VEGF was successfully constructed. The VEGF mRNA expression levels in blank control group, experimental group (pU6-VEGF) and negative control group (pSilencer1.0-U6) were 100%, 49% and 94%, respectively, indicating VEGF mRNA expression in the cells transfected with pU-VEGF vector was inhibited significantly as compared with blank control group and negative control group. It was concluded that the short hairpin RNA could significantly inhibit the expression of VEGF mRNA, which provided an experimental basis for treating human cancer with anti-angiogenesis.

Keywords

RNA interference / vascular endothelial growth factor / gastric cancer

References

[1] MathersC. D., FatD. M., InoueM., et al.. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ, 2005, 83(3): 171-177

[2] LeungD. W., CachianesG., KuangW. J., et al.. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 1989, 246(4935): 1306-1309

[3] RheeJ., HoffP. M.. Angiogenesis inhibitors in the treatment of cancer. Expert Opin Pharmacother, 2005, 6(10): 1701-1711

[4] NamD. H., ParkK., SuhY. L., et al.. Expression of VEGF and brain specific angiogenesis inhibitor-1 in glioblastoma: prognostic significance. Oncol Rep, 2004, 11(4): 863-869

[5] WannenesF., CiafreS. A., NiolaF., et al.. Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo. Cancer Gene Ther, 2005, 12(12): 926-934

[6] ChengJ. C., MooreT. B., SakamotoK. M.. RNA interference and human disease. Mol Genet Metab, 2003, 80(1–2): 121-128

[7] ElbashirS. M., LendeckelW., TuschlT.. RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev, 2001, 15(2): 188-200

[8] KonnoH., BabaM., TanakaT., et al.. Overexpression of vascular endothelial growth factor is responsible for the hematogenous recurrence of early-stage gastric carcinoma. Eur Surg Res, 2000, 32(3): 177-181

[9] SuiG., SoohooC., el AffarB., et al.. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA, 2002, 99(8): 5515-5520